131 related articles for article (PubMed ID: 10889376)
1. Progesterone receptor is a favorable prognostic factor of radiation therapy for adenocarcinoma of the uterine cervix.
Suzuki Y; Nakano T; Arai T; Morita S; Tsujii H; Oka K
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(5):1229-34. PubMed ID: 10889376
[TBL] [Abstract][Full Text] [Related]
2. Adenocarcinoma of the cervix. Expression and clinical significance of estrogen and progesterone receptors.
Fujiwara H; Tortolero-Luna G; Mitchell MF; Koulos JP; Wright TC
Cancer; 1997 Feb; 79(3):505-12. PubMed ID: 9028361
[TBL] [Abstract][Full Text] [Related]
3. Expression and prognostic significance of estrogen and progesterone receptors in adenocarcinoma of the uterine cervix. An immunocytochemical study.
Masood S; Rhatigan RM; Wilkinson EW; Barwick KW; Wilson WJ
Cancer; 1993 Jul; 72(2):511-8. PubMed ID: 8319181
[TBL] [Abstract][Full Text] [Related]
4. Oestrogen increases S-phase fraction and oestrogen and progesterone receptors in human cervical cancer in vivo.
Bhattacharya D; Redkar A; Mittra I; Sutaria U; MacRae KD
Br J Cancer; 1997; 75(4):554-8. PubMed ID: 9052410
[TBL] [Abstract][Full Text] [Related]
5. Study of estrogen receptor, progesterone receptor, and the estrogen-regulated Mr 24,000 protein in patients with carcinomas of the endometrium and cervix.
Ciocca DR; Puy LA; Fasoli LC
Cancer Res; 1989 Aug; 49(15):4298-304. PubMed ID: 2743317
[TBL] [Abstract][Full Text] [Related]
6. c-erbB-2 oncoprotein overexpression in uterine cervix carcinoma with glandular differentiation. A frequent event but not an independent prognostic marker because it occurs late in the disease.
Costa MJ; Walls J; Trelford JD
Am J Clin Pathol; 1995 Dec; 104(6):634-42. PubMed ID: 8526205
[TBL] [Abstract][Full Text] [Related]
7. Immunocytochemical localization of oestrogen and progesterone receptors in primary adenocarcinoma of the cervix.
Ghandour FA; Attanoos R; Nahar K; Gee JW; Bigrigg A; Ismail SM
Histopathology; 1994 Jan; 24(1):49-55. PubMed ID: 8144142
[TBL] [Abstract][Full Text] [Related]
8. High-dose-rate intracavitary brachytherapy combined with external beam radiotherapy for stage IIIb adenocarcinoma of the uterine cervix in Japan: a multi-institutional study of Japanese Society of Therapeutic Radiology and Oncology 2006-2007 (study of JASTRO 2006-2007).
Niibe Y; Kenjo M; Onishi H; Ogawa Y; Kazumoto T; Ogino I; Tsujino K; Harima Y; Takahashi T; Anbai A; Tsuchida E; Toita T; Takemoto M; Yamashita H; Hayakawa K
Jpn J Clin Oncol; 2010 Aug; 40(8):795-9. PubMed ID: 20444747
[TBL] [Abstract][Full Text] [Related]
9. Oestrogen and progesterone receptors in carcinoma of the cervix.
Harding M; McIntosh J; Paul J; Symonds RP; Reed N; Habeshaw T; Stewart M; Leake RE
Clin Oncol (R Coll Radiol); 1990 Nov; 2(6):313-7. PubMed ID: 2278888
[TBL] [Abstract][Full Text] [Related]
10. Ki-67 staining in benign, borderline, malignant primary and metastatic ovarian tumors: correlation with steroid receptors, epidermal-growth-factor receptor and cathepsin D.
Henzen-Logmans SC; Fieret EJ; Berns EM; van der Burg ME; Klijn JG; Foekens JA
Int J Cancer; 1994 May; 57(4):468-72. PubMed ID: 8181851
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical study of cell cycle-associated proteins in adenocarcinoma of the uterine cervix treated with radiotherapy alone: P53 status has a strong impact on prognosis.
Suzuki Y; Nakano T; Kato S; Ohno T; Tsujii H; Oka K
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):231-6. PubMed ID: 15337561
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome and prognostic factors for adenocarcinoma/adenosquamous carcinoma of cervix after definitive radiotherapy.
Huang YT; Wang CC; Tsai CS; Lai CH; Chang TC; Chou HH; Hsueh S; Chen CK; Lee SP; Hong JH
Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):429-36. PubMed ID: 20542643
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors for local and distant recurrence in stage I and II cervical carcinoma.
Werner-Wasik M; Schmid CH; Bornstein L; Ball HG; Smith DM; Madoc-Jones H
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1309-17. PubMed ID: 7635770
[TBL] [Abstract][Full Text] [Related]
14. Differential clinical characteristics, treatment response and prognosis of locally advanced adenocarcinoma/adenosquamous carcinoma and squamous cell carcinoma of cervix treated with definitive radiotherapy.
Chen JL; Huang CY; Huang YS; Chen RJ; Wang CW; Chen YH; Cheng JC; Cheng AL; Kuo SH
Acta Obstet Gynecol Scand; 2014 Jul; 93(7):661-8. PubMed ID: 24666257
[TBL] [Abstract][Full Text] [Related]
15. Adenocarcinoma of the cervix treated with radiation alone: prognostic significance of S-100 protein and vimentin immunostaining.
Oka K; Nakano T; Arai T
Obstet Gynecol; 1992 Mar; 79(3):347-50. PubMed ID: 1738512
[TBL] [Abstract][Full Text] [Related]
16. Estrogen and progesterone receptors in normal cervix and primary cervical carcinoma.
Shen K; Yueng W; Ngan H
Chin Med J (Engl); 1994 Sep; 107(9):648-52. PubMed ID: 7805454
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of vascular endothelial growth factor in Stage IB carcinoma of the uterine cervix.
Lee IJ; Park KR; Lee KK; Song JS; Lee KG; Lee JY; Cha DS; Choi HI; Kim DH; Deung YK
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):768-79. PubMed ID: 12377329
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of estrogen and progesterone receptors in primary breast cancer.
Saez S; Cheix F; Asselain B
Breast Cancer Res Treat; 1983; 3(4):345-53. PubMed ID: 6667349
[TBL] [Abstract][Full Text] [Related]
19. [Estrogen and progesterone receptors in normal cervix and primary cervical carcinoma].
Shen K; Yueng W; Ngan H
Zhonghua Fu Chan Ke Za Zhi; 1994 May; 29(5):284-8, 317-8. PubMed ID: 7956553
[TBL] [Abstract][Full Text] [Related]
20. Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix?
Shingleton HM; Bell MC; Fremgen A; Chmiel JS; Russell AH; Jones WB; Winchester DP; Clive RE
Cancer; 1995 Nov; 76(10 Suppl):1948-55. PubMed ID: 8634986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
